171 related articles for article (PubMed ID: 7992831)
21. [Histopathology of the central nervous system in amyotrophic lateral sclerosis. III. Inflammatory factor of amyotrophic lateral sclerosis].
KHONDKARIAN OA
Zh Nevropatol Psikhiatr Im S S Korsakova; 1955; 55(10):755-8. PubMed ID: 13300956
[No Abstract] [Full Text] [Related]
22. Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation.
Gurney ME; Pu H; Chiu AY; Dal Canto MC; Polchow CY; Alexander DD; Caliendo J; Hentati A; Kwon YW; Deng HX
Science; 1994 Jun; 264(5166):1772-5. PubMed ID: 8209258
[TBL] [Abstract][Full Text] [Related]
23. Secreted Metabolome of ALS-Related hSOD1(G93A) Primary Cultures of Myocytes and Implications for Myogenesis.
Stella R; Bonadio RS; Cagnin S; Andreotti R; Massimino ML; Bertoli A; Peggion C
Cells; 2023 Nov; 12(23):. PubMed ID: 38067180
[TBL] [Abstract][Full Text] [Related]
24. Microglial crosstalk with astrocytes and immune cells in amyotrophic lateral sclerosis.
Calafatti M; Cocozza G; Limatola C; Garofalo S
Front Immunol; 2023; 14():1223096. PubMed ID: 37564648
[TBL] [Abstract][Full Text] [Related]
25. The 2-Oxoglutarate Carrier Is S-Nitrosylated in the Spinal Cord of G93A Mutant hSOD1 Mice Resulting in Disruption of Mitochondrial Glutathione Transport.
Linseman DA; Winter AN; Wilkins HM
Biomedicines; 2022 Dec; 11(1):. PubMed ID: 36672568
[TBL] [Abstract][Full Text] [Related]
26. Identification of quantitative trait loci for survival in the mutant dynactin p150Glued mouse model of motor neuron disease.
Alexander GM; Heiman-Patterson TD; Bearoff F; Sher RB; Hennessy L; Terek S; Caccavo N; Cox GA; Philip VM; Blankenhorn EA
PLoS One; 2022; 17(9):e0274615. PubMed ID: 36107978
[TBL] [Abstract][Full Text] [Related]
27. Altered Bioenergetics and Metabolic Homeostasis in Amyotrophic Lateral Sclerosis.
Nelson AT; Trotti D
Neurotherapeutics; 2022 Jul; 19(4):1102-1118. PubMed ID: 35773551
[TBL] [Abstract][Full Text] [Related]
28. Accumulation of misfolded SOD1 outlines distinct patterns of motor neuron pathology and death during disease progression in a SOD1
Salvany S; Casanovas A; Piedrafita L; Gras S; Calderó J; Esquerda JE
Brain Pathol; 2022 Nov; 32(6):e13078. PubMed ID: 35584812
[TBL] [Abstract][Full Text] [Related]
29. SOD1 in ALS: Taking Stock in Pathogenic Mechanisms and the Role of Glial and Muscle Cells.
Peggion C; Scalcon V; Massimino ML; Nies K; Lopreiato R; Rigobello MP; Bertoli A
Antioxidants (Basel); 2022 Mar; 11(4):. PubMed ID: 35453299
[TBL] [Abstract][Full Text] [Related]
30. Small Hexokinase 1 Peptide against Toxic SOD1 G93A Mitochondrial Accumulation in ALS Rescues the ATP-Related Respiration.
Magrì A; Risiglione P; Caccamo A; Formicola B; Tomasello MF; Arrigoni C; Zimbone S; Guarino F; Re F; Messina A
Biomedicines; 2021 Aug; 9(8):. PubMed ID: 34440152
[TBL] [Abstract][Full Text] [Related]
31. The feeding behaviour of Amyotrophic Lateral Sclerosis mouse models is modulated by the Ca
Cocozza G; Garofalo S; Morotti M; Chece G; Grimaldi A; Lecce M; Scavizzi F; Menghini R; Casagrande V; Federici M; Raspa M; Wulff H; Limatola C
Br J Pharmacol; 2021 Dec; 178(24):4891-4906. PubMed ID: 34411281
[TBL] [Abstract][Full Text] [Related]
32. Progressive Mitochondrial SOD1
Méndez-López I; Sancho-Bielsa FJ; Engel T; García AG; Padín JF
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360957
[TBL] [Abstract][Full Text] [Related]
33. Selective Neuron Vulnerability in Common and Rare Diseases-Mitochondria in the Focus.
Paß T; Wiesner RJ; Pla-Martín D
Front Mol Biosci; 2021; 8():676187. PubMed ID: 34295920
[TBL] [Abstract][Full Text] [Related]
34. Potential Roles of the WNT Signaling Pathway in Amyotrophic Lateral Sclerosis.
Jiang X; Guan Y; Zhao Z; Meng F; Wang X; Gao X; Liu J; Chen Y; Zhou F; Zhou S; Wang X
Cells; 2021 Apr; 10(4):. PubMed ID: 33917816
[TBL] [Abstract][Full Text] [Related]
35. Behavioral, Hormonal, Inflammatory, and Metabolic Effects Associated with FGF21-Pathway Activation in an ALS Mouse Model.
Delaye JB; Lanznaster D; Veyrat-Durebex C; Fontaine A; Bacle G; Lefevre A; Hergesheimer R; Lecron JC; Vourc'h P; Andres CR; Maillot F; Corcia P; Emond P; Blasco H
Neurotherapeutics; 2021 Jan; 18(1):297-308. PubMed ID: 33021723
[TBL] [Abstract][Full Text] [Related]
36. Reduced mitochondrial D-loop methylation levels in sporadic amyotrophic lateral sclerosis.
Stoccoro A; Smith AR; Mosca L; Marocchi A; Gerardi F; Lunetta C; Cereda C; Gagliardi S; Lunnon K; Migliore L; Coppedè F
Clin Epigenetics; 2020 Sep; 12(1):137. PubMed ID: 32917270
[TBL] [Abstract][Full Text] [Related]
37. Peroxisome Proliferator Activator Receptor Gamma Coactivator-1α Overexpression in Amyotrophic Lateral Sclerosis: A Tale of Two Transgenics.
Varghese M; Zhao W; Trageser KJ; Pasinetti GM
Biomolecules; 2020 May; 10(5):. PubMed ID: 32414179
[TBL] [Abstract][Full Text] [Related]
38. A VDAC1-Derived N-Terminal Peptide Inhibits Mutant SOD1-VDAC1 Interactions and Toxicity in the SOD1 Model of ALS.
Shteinfer-Kuzmine A; Argueti S; Gupta R; Shvil N; Abu-Hamad S; Gropper Y; Hoeber J; Magrì A; Messina A; Kozlova EN; Shoshan-Barmatz V; Israelson A
Front Cell Neurosci; 2019; 13():346. PubMed ID: 31474832
[TBL] [Abstract][Full Text] [Related]
39. CNS-derived extracellular vesicles from superoxide dismutase 1 (SOD1)
Silverman JM; Christy D; Shyu CC; Moon KM; Fernando S; Gidden Z; Cowan CM; Ban Y; Stacey RG; Grad LI; McAlary L; Mackenzie IR; Foster LJ; Cashman NR
J Biol Chem; 2019 Mar; 294(10):3744-3759. PubMed ID: 30635404
[TBL] [Abstract][Full Text] [Related]
40. Activation of Phosphotyrosine-Mediated Signaling Pathways in the Cortex and Spinal Cord of SOD1
Mallozzi C; Spalloni A; Longone P; Domenici MR
Neural Plast; 2018; 2018():2430193. PubMed ID: 30154836
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
